{"entity":{"id":"src-stat-news","kind":"collection","name":"STAT News","aka":[],"tldr":"STAT News has the best-written reporting on the science and business of cancer, with real scepticism.","summary":"STAT News publishes health and biotech journalism across cancer science, drug pricing, policy and industry, with some of the best-written and most sceptical reporting on the science and business of cancer. It publishes daily from Boston Globe Media and is strong on radiopharmaceuticals, mRNA vaccines, access after approval and FDA politics. Access is freemium with a STAT+ subscription. On OnCo it is listed as a source with the tags source and news.","asOf":"2026-09-08","links":[{"label":"STAT News","url":"https://www.statnews.com/topic/cancer/"}],"tags":["source","news"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.statnews.com/topic/cancer/","holds":"Health and biotech journalism: cancer science, drug pricing, policy, and industry.","license":"Freemium; STAT+ subscription","maintainer":"Boston Globe Media"},"route":"/collections/src-stat-news/","neighbours":{"company":[{"id":"nimbus-therapeutics","kind":"company","name":"Nimbus Therapeutics","route":"/companies/nimbus-therapeutics/"}]}}